Press releases

JSR Establishes US Headquarters for JSR Life Sciences and North American Holding Company

SUNNYVALE, CA – Mar. 14, 2019 – JSR announced today that it will establish a US headquarters for its biotechnology and life sciences focused businesses under the name JSR Life Sciences, LLC effective April 1, 2019.  The formation of JSR Life Sciences will centralize leadership and resources to support the company’s value proposition of driving innovation to provide a portfolio of integrated products, services and technologies to help partners develop and commercialize therapeutics and diagnostics that benefit global human health.

Read more Read more about JSR Establishes US Headquarters for JSR Life Sciences and North American Holding Company

Aspect Biosystems Announces Liver Tissue Collaboration with JSR

Vancouver, Canada - September 18, 2018 - Aspect Biosystems, a privately held biotechnology company focused on commercializing cutting-edge bioprinting technologies, is pleased to announce a new collaboration to develop human liver tissue with JSR Corporation, a leading materials supplier in a variety of technology driven markets. Through this collaboration, Aspect’s proprietary Lab-on-a-Printer™ 3D bioprinting platform and JSR’s advanced materials technology will be used to develop vascularized human liver lobules.  

Read more Read more about Aspect Biosystems Announces Liver Tissue Collaboration with JSR

Oxford Performance Materials and JSR Corporation Announce Partnership to Advance OPM Technology Platform Throughout Asia

SOUTH WINDSOR, Conn. and TOKYO - May 14, 2018 - Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM®), and Tokyo-based JSR Corporation (JSR), a leading materials supplier in a variety of technology driven markets, today announced a partnership to advance OPM’s poly-ether-ketone-ketone (PEKK)-based 3D-printed orthopedic devices and biomedical & dental materials businesses throughout Asia. 

Read more Read more about Oxford Performance Materials and JSR Corporation Announce Partnership to Advance OPM Technology Platform Throughout Asia

JSR Announces Acquisition of Crown Biosciences International

TOKYO – Dec. 20, 2017 – JSR Life Sciences (JLS) announced today that JSR Corporation has agreed to purchase Crown Bioscience International (TPEx: ticker 6554) at 12 Billion New Taiwan Dollar, a global drug discovery and development services company providing translational platforms to advanced oncology, inflammation, cardiovascular and metabolic disease research.  This acquisition marks JSR’s largest life sciences-focused investment to date, extending the company’s portfolio to include industry-leading contract research and development capabilities

Read more Read more about JSR Announces Acquisition of Crown Biosciences International

JSR Corporation Establishes JSR Life Sciences Division, Names North American Leader

April 14, 2016 – Sunnyvale, CA – JSR Life Sciences Division (JLS) today announced the formation and establishment of its global corporate headquarters in Sunnyvale, CA USA. Eric R. Johnson will assume responsibility of all operations as Senior Executive Officer and General Manager Life Sciences Division. JLS US headquarters will be responsible for all commercial business activities including strategic planning, customer support, marketing and product development oversight.

Read more Read more about JSR Corporation Establishes JSR Life Sciences Division, Names North American Leader
1